Inflammation-mediated memory dysfunction and effects of a ketogenic diet in a murine model of multiple sclerosis

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Kim, Do Young ^a   Hao, Junwei ^a,b   Liu, Ruolan ^a   Turner, Gregory ^a   Shi, Fu Dong ^a,b   Rho, Jong M ^a,c  

^a BARROW NEUROLOGICAL INSTITUTE   (United States)

^b TIANJIN MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; REACTIVE OXYGEN METABOLITE;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; ELECTROPHYSIOLOGY; ENCEPHALITIS; FEMALE; HIPPOCAMPAL CA1 REGION; IMMUNE RESPONSE; IN VIVO STUDY; KETOGENIC DIET; LEARNING DISORDER; LONG TERM POTENTIATION; MALE; MAZE TEST; MEMORY; MEMORY DISORDER; MOTOR DYSFUNCTION; MOUSE; MULTIPLE SCLEROSIS; NERVE CELL PLASTICITY; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; OXIDATIVE STRESS; SYMPTOMATOLOGY; ANIMAL; BRAIN; C57BL MOUSE; FLOW CYTOMETRY; IMMUNOLOGY; INFLAMMATION; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALIA; MURINAE; MUS;

ANIMALS; BRAIN; CENTRAL NERVOUS SYSTEM; ELECTROPHYSIOLOGY; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FLOW CYTOMETRY; INFLAMMATION; LONG-TERM POTENTIATION; MAGNETIC RESONANCE IMAGING; MEMORY DISORDERS; MICE; MICE, INBRED C57BL; MULTIPLE SCLEROSIS; REACTIVE OXYGEN SPECIES;

EID: 84860494814     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0035476     Document Type: Article

References (48)

1. Rao SM, Leo GJ, Bernardin L, Unverzagt F, (1991) Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 41: 685-691.
2. Amato MP, Portaccio E, Stromillo ML, Goretti B, Zipoli V, et al. (2008) Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis. Neurology 71: 632-638.
3. Sicotte NL, Kern KC, Giesser BS, Arshanapalli A, Schultz A, et al. (2008) Regional hippocampal atrophy in multiple sclerosis. Brain 131: 1134-1141.
4. Roosendaal SD, Moraal B, Pouwels PJ, Vrenjen H, Castelijns JA, et al. (2009) Accumulation of cortical lesions in MS: relation with cognitive impairment. Mult Scler 15: 708-714.
5. Ziehn MO, Avedisian AA, Tiwari-Woodruff S, Voskuhl RR, (2010) Hippocampal CA1 atrophy and synaptic loss during experimental autoimmune encephalomyelitis, EAE. Lab Invest 90: 774-786.
6. Amato MP, Zipoli V, Goretti B, Portaccio E, De Caro MF, et al. (2006) Benign multiple sclerosis: cognitive, psychological and social aspects in a clinical cohort. J Neurol 253: 1054-1059.
7. Steinman L, (2001) Multiple sclerosis: a two-stage disease. Nat Immunol 2: 762-764.
8. Sutton C, Brereton C, Keogh B, Mills KH, Lavelle EC, (2006) A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J Exp Med 203: 1685-1691.
9. Ruuls SR, Bauer J, Sontrop K, Huitinga I, 't Hart BA, et al. (1995) Reactive oxygen species are involved in the pathogenesis of experimental allergic encephalomyelitis in Lewis rats. J Neuroimmunol 56: 207-217.
10. van Horssen J, Schreibelt G, Drexhage J, Hazes T, Dijkstra CD, et al. (2008) Severe oxidative damage in multiple sclerosis lesions coincides with enhanced antioxidant enzyme expression. Free Radic Biol Med 45: 1729-1737.
11. Heyser CJ, Masliah E, Samimi A, Campbell, Gold LH, (1997) Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain. Proc Natl Acad Sci U S A 94: 1500-1505.
12. Fang F, Lue LF, Yan S, Xu H, Luddy JS, et al. (2010) RAGE-dependent signaling in microglia contributes to neuroinflammation, Abeta accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease. Faseb J 24: 1043-1055.
13. Giuliani F, Vernay A, Leuba G, Schenk F, (2009) Decreased behavioral impairments in an Alzheimer mice model by interfering with TNF-alpha metabolism. Brain Res Bull 80: 302-308.
14. Kamsler A, Segal M, (2003) Hydrogen peroxide modulation of synaptic plasticity. J Neurosci 23: 269-276.
15. Neal EG, Chaffe H, Schwartz RH, Lawson MS, Edwards N, et al. (2008) The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Lancet Neurol 7: 500-506.
16. Van der Auwera I, Wera S, Van Leuven F, Henderson ST, (2005) A ketogenic diet reduces amyloid beta 40 and 42 in a mouse model of Alzheimer's disease. Nutr Metab (Lond) 2: 28.
17. Zhao Z, Lange DJ, Voustianiouk A, MacGrogan D, Ho L, et al. (2006) A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis. BMC Neurosci 7: 29.
18. Ruskin DN, Kawamura M, Masino SA, (2009) Reduced pain and inflammation in juvenile and adult rats fed a ketogenic diet. PLoS One 4: e8349.
19. Sullivan PG, Rippy NA, Dorenbos K, Concepcion RC, Agarwal AK, et al. (2004) The ketogenic diet increases mitochondrial uncoupling protein levels and activity. Ann Neurol 55: 576-580.
20. Kocer B, Unal T, Nazliel B, Biyikli Z, Yesilbudak Z, et al. (2008) Evaluating sub-clinical cognitive dysfunction and event-related potentials (P300) in clinically isolated syndrome. Neurol Sci 29: 435-444.
21. Liu R, Bai Y, Vollmer TL, Bai XF, Jee Y, et al. (2008) IL-21 receptor expression determines the temporal phases of experimental autoimmune encephalomyelitis. Exp Neurol 211: 14-24.
22. Miller D, Barkhof F, Montalban X, Thompson A, Filippi M, (2005) Clinically isolated syndromes suggestive of multiple sclerosis, part 2: non-conventional MRI, recovery processes, and management. Lancet Neurol 4: 341-348.
23. Tiemann L, Penner IK, Haupts M, Schlegel U, Calabrese P, (2009) Cognitive decline in multiple sclerosis: impact of topographic lesion distribution on differential cognitive deficit patterns. Mult Scler 15: 1164-1174.
24. Zozulya AL, Wiendl H, (2008) The role of regulatory T cells in multiple sclerosis. Nat Clin Pract Neurol 4: 384-398.
25. Wada-Isoe K, Wakutani Y, Urakami K, Nakashima K, (2004) Elevated interleukin-6 levels in cerebrospinal fluid of vascular dementia patients. Acta Neurol Scand 110: 124-127.
26. Wan Y, Xu J, Ma D, Zeng Y, Cibelli M, et al. (2007) Postoperative impairment of cognitive function in rats: a possible role for cytokine-mediated inflammation in the hippocampus. Anesthesiology 106: 436-443.
27. Kimura A, Kishimoto T, (2010) IL-6: regulator of Treg/Th17 balance. Eur J Immunol 40: 1830-1835.
28. Jana M, Pahan K, (2005) Redox regulation of cytokine-mediated inhibition of myelin gene expression in human primary oligodendrocytes. Free Radic Biol Med 39: 823-831.
29. Mattsson N, Haghighi S, Andersen O, Yao Y, Rosengren L, et al. (2007) Elevated cerebrospinal fluid F2-isoprostane levels indicating oxidative stress in healthy siblings of multiple sclerosis patients. Neurosci Lett 414: 233-236.
30. LeVine SM, (1992) The role of reactive oxygen species in the pathogenesis of multiple sclerosis. Med Hypotheses 39: 271-274.
31. Bo L, Dawson TM, Wesselingh S, Mörk S, Choi S, et al. (1994) Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann Neurol 36: 778-786.
32. Jarrett SG, Milder JB, Liang LP, Patel M, (2008) The ketogenic diet increases mitochondrial glutathione levels. J Neurochem 106: 1044-1051.
33. Kim do Y, Vallejo J, Rho JM, (2010) Ketones prevent synaptic dysfunction induced by mitochondrial respiratory complex inhibitors. J Neurochem 114: 130-141.
34. Papadopoulos D, Dukes S, Patel R, Nicholas R, Vora A, et al. (2009) Substantial archaeocortical atrophy and neuronal loss in multiple sclerosis. Brain Pathol 19: 238-253.
35. Kim DY, Rho JM, (2008) The ketogenic diet and epilepsy. Curr Opin Clin Nutr Metab Care 11: 113-120.
36. Honors MA, Davenport BM, Kinzig KP, (2009) Effects of consuming a high carbohydrate diet after eight weeks of exposure to a ketogenic diet. Nutr Metab (Lond) 6: 46.
37. Mohamed HE, El-Swefy SE, Rashed LA, Abd El-Latif SK, (2010) Biochemical effect of a ketogenic diet on the brains of obese adult rats. J Clin Neurosci 17: 899-904.
38. Kang JX, Weylandt KH, (2008) Modulation of inflammatory cytokines by omega-3 fatty acids. Subcell Biochem 49: 133-143.
39. Farinotti M, Simi S, Di Pietrantonj C, McDowell N, Brait L, et al. (2007) Dietary interventions for multiple sclerosis. Cochrane Database Syst Rev CD004192.
40. Mehta LR, Dworkin RH, Schwid SR, (2009) Polyunsaturated fatty acids and their potential therapeutic role in multiple sclerosis. Nat Clin Pract Neurol 5: 82-92.
41. Shinto L, Marracci G, Baldauf-Wagner S, Stehlow A, Yadav V, et al. (2009) Omega-3 fatty acid supplementation decreases matrix metalloproteinase-9 production in relapsing-remitting multiple sclerosis. Prostaglandins Leukot Essent Fatty Acids 80: 131-136.
42. Yadav V, Shinto L, Bourdette D, (2010) Complementary and alternative medicine for the treatment of multiple sclerosis. Expert Rev Clin Immunol 6: 381-395.
43. Piccio L, Stark JL, Cross AH, (2008) Chronic calorie restriction attenuates experimental autoimmune encephalomyelitis. J Leukoc Biol 84: 940-948.
44. Fantuzzi G, (2005) Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115: 911-919.
45. Matarese G, Moschos S, Mantzoros CS, (2005) Leptin in immunology. J Immunol 174: 3137-3142.
46. Trapp BD, Stys PK, (2009) Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis. Lancet Neurol 8: 280-291.
47. Vogler S, Pahnke J, Rousset S, Ricquier D, Moch H, et al. (2006) Uncoupling protein 2 has protective function during experimental autoimmune encephalomyelitis. Am J Pathol 168: 1570-1575.
48. Bough KJ, Wetherington J, Hassel B, Pare JF, Gawryluk JW, et al. (2006) Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet. Ann Neurol 60: 223-235.